It is reported that ~70% of lv-PPA patients have underlying Alzheimer pathology, ~70% of nfv-PPA have tauopathy, and ~85% of sv-PPA have TDP−43, and that detailed and careful clinical, cognitive, and imaging examination improves this pathological correspondence [48,49,50]. The gene discussed is TARDBP; the disease is primary progressive aphasia.